Publications

Detailed Information

Cyclooxygenase-2 Expression in Cervical Intraepithelial Neoplasia

DC Field Value Language
dc.contributor.authorKim, Kidong-
dc.contributor.authorJeon, Yong-Tark-
dc.contributor.authorPark, In-Ae-
dc.contributor.authorKim, Jae Weon-
dc.contributor.authorKang, Soon-Beom-
dc.contributor.authorSong, Yong-Sang-
dc.contributor.authorLee, Hyo-Pyo-
dc.contributor.authorPark, Noh-Hyun-
dc.date.accessioned2012-05-30T05:56:47Z-
dc.date.available2012-05-30T05:56:47Z-
dc.date.issued2009-
dc.identifier.citationAnnals of the New York Academy of Sciences; Vol.1171 ; 111-115ko_KR
dc.identifier.issn0077-8923-
dc.identifier.urihttps://hdl.handle.net/10371/76620-
dc.description.abstractTo evaluate the role of cyclooxygenase (COX)-2 during cervical carcinogenesis, we investigated COX-2 expression in the dysplastic epithelium and stromal cells of cervical intraepithelial neoplasia (CIN). Immunohistochemical analysis with COX-2 antibody was performed on 148 paraffin-embedded tissue specimens of patients who were diagnosed as CIN in our institute. COX-2 expression was evaluated separately in the dysplastic epithelium and stromal cells of CIN. The relationships between COX-2 expression and clinicopathologic variables were examined. For the dysplastic epithelium, COX-2 expression was negative in 137 (92.6%) and positive in 11 (7.4%) specimens. For the stromal cells, COX-2 expression was negative in all specimens. The COX-2 expression in dysplastic epithelium was higher in older (P = 0.038) or postmenopausal (P = 0.025) women. In conclusion, COX-2 expression was observed only in the dysplastic epithelium but not in the stromal cells of CIN. The COX-2 expression in dysplastic epithelium was associated with age and menopausal status.ko_KR
dc.language.isoenko_KR
dc.publisherBLACKWELL PUBLISHINGko_KR
dc.subjectcyclooxygenase-2ko_KR
dc.subjectcervical intraepithelial neoplasia (CIN)ko_KR
dc.subjectmenopauseko_KR
dc.subjectstromal cellsko_KR
dc.subjectepitheliumko_KR
dc.subjectage factorsko_KR
dc.titleCyclooxygenase-2 Expression in Cervical Intraepithelial Neoplasiako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김기동-
dc.contributor.AlternativeAuthor전용탁-
dc.contributor.AlternativeAuthor박인애-
dc.contributor.AlternativeAuthor김재원-
dc.contributor.AlternativeAuthor박노현-
dc.contributor.AlternativeAuthor강순범-
dc.contributor.AlternativeAuthor이효표-
dc.contributor.AlternativeAuthor송용상-
dc.identifier.doi10.1111/j.1749-6632.2009.04724.x-
dc.citation.journaltitleNATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS-
dc.description.citedreferenceSubbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273-
dc.description.citedreferenceDursun P, 2007, INT J GYNECOL CANCER, V17, P164, DOI 10.1111/j.1525-1438.2007.00798.x-
dc.description.citedreferenceLee TS, 2007, ANN NY ACAD SCI, V1095, P143, DOI 10.1196/annals.1397.018-
dc.description.citedreferenceHardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112-
dc.description.citedreferenceKang SB, 2006, CANCER LETT, V237, P305, DOI 10.1016/j.canlet.2005.06.027-
dc.description.citedreferenceKim JY, 2005, GYNECOL ONCOL, V97, P337, DOI 10.1016/j.ygyno.2004.09.012-
dc.description.citedreferenceDai YM, 2005, GYNECOL ONCOL, V97, P96, DOI 10.1016/j.ygyno.2004.12.020-
dc.description.citedreferenceJeon YT, 2004, CANCER EPIDEM BIOMAR, V13, P1538-
dc.description.citedreferenceSheehan KM, 2004, EUR J GASTROEN HEPAT, V16, P619, DOI 10.1097/01.meg.000108313.52416.38-
dc.description.citedreferenceSeo SS, 2004, GYNECOL ONCOL, V92, P927, DOI 10.1016/j.ygyno.2003.11.055-
dc.description.citedreferenceLin H, 2004, INT J GYNECOL CANCER, V14, P311-
dc.description.citedreferenceFarley J, 2004, GYNECOL ONCOL, V92, P596, DOI 10.1016/j.ygyno.2003.10.052-
dc.description.citedreferenceKim MH, 2003, GYNECOL ONCOL, V90, P83, DOI 10.1016/S0090-8258(03)00224-5-
dc.description.citedreferenceKawada M, 2003, DIGESTION, V67, P20, DOI 10.1159/000069708-
dc.description.citedreferenceFerrandina G, 2002, BRIT J CANCER, V87, P1145, DOI 10.1038/sj.bjc.6600578-
dc.description.citedreferenceKim YB, 2002, CANCER, V95, P531, DOI 10.1002/cncr.10684-
dc.description.citedreferenceSurh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X-
dc.description.citedreferenceWilliams CS, 2000, J CLIN INVEST, V105, P1589-
dc.description.citedreferencePrescott SM, 2000, J CLIN INVEST, V105, P1511-
dc.description.citedreferenceWilliams CS, 1999, ONCOGENE, V18, P7908-
dc.description.citedreferenceTjalma W, 1999, AM J OBSTET GYNECOL, V181, P554-
dc.description.citedreferenceWilliams C, 1999, ANN NY ACAD SCI, V889, P72-
dc.description.citedreferenceKinzler KW, 1998, SCIENCE, V280, P1036-
dc.description.citedreferenceOshima M, 1996, CELL, V87, P803-
dc.description.citedreferenceMUNGER K, 1992, CANCER SURV, V12, P197-
dc.description.tc1-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share